arrow
F

Francesco Schettini

idibaps
H指数:32
被引数:4,637

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A Mixed Probiotic/Prebiotic Intervention (MBR-01) for the Management of Diarrhea During Abemaciclib Treatment of Early Breast Cancer in Postmenopausal Patients: A Single-Center Prospective Case–Control Pilot Study

一种用于绝经后早期乳腺癌患者接受阿贝西利治疗期间腹泻管理的复合益生菌/益生元干预(MBR-01):一项单中心前瞻性病例对照试点研究

2026-06-010
OA
Virtual Biomarkers and Simplified Metrics in the Modeling of Breast Cancer Neoadjuvant Therapy: A Proof-of-Concept Case Study Based on Diagnostic Imaging
2025-10-240
OA
Ki67 dynamic predicts endocrine sensitivity in estrogen receptor-positive/HER2-negative breast cancer patients undergoing preoperative endocrine therapy

Ki67动态变化可预测接受术前内分泌治疗的雌激素受体阳性/HER2阴性乳腺癌患者的内分泌敏感性。

2025-10-160
OAAI
Genomic and clinical features in young women with estrogen receptor-positive, HER2-negative breast cancer

雌激素受体阳性、HER2阴性乳腺癌年轻女性的基因组与临床特征

2025-09-240
PREAI
Paclitaxel-related type I Kounis Syndrome in a very young patient with HER2-positive breast cancer and the role of genomics to disentangle a complex therapeutic scenario: a case report and narrative review

紫杉醇相关性Kounis综合征I型:1例年轻HER2阳性乳腺癌患者报告及基因组学在阐明复杂治疗情境中作用:病例报告及综述

BREAST
IF7.9
2025-06-010
OAAI
Clinical characteristics and prognostic factors in patients with breast cancer and leptomeningeal metastases from a large registry of BMBC

乳腺癌并发软脑膜转移患者的临床特征与预后因素:来自BMBC大型注册研究的数据

BREAST
IF7.9
2025-06-010
OAAI
Linking tumor immune infiltration to enhanced longevity in recurrence-free breast cancer
2025-01-010
OAAI
Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptorpositive/HER2-negative breast cancer: the NEOENDO translational study
2024-12-011
PRE
Identifying the best treatment choice for relapsing/refractory glioblastoma: a systematic review with multiple Bayesian network meta-analyses

确定复发性/难治性胶质母细胞瘤的最佳治疗方案:一项包含多次贝叶斯网络荟萃分析的系统性综述

2024-12-012
OA
Toxicities in breast cancer patients undergoing neoadjuvant immune checkpoint inhibitor therapy: Insights from a nurse practitioner perspective

乳腺癌患者在接受新辅助免疫检查点抑制剂治疗时的毒副反应:从执业护士角度的见解

2024-09-010
PRE
Brain imaging screening (BIS) in metastatic breast cancer (MBC): Patients' and physicians' perspectives

脑成像筛查(BIS)在转移性乳腺癌(MBC)中的应用:患者与医生的视角

2024-09-010
PRE
Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study

MammaTyper对新辅助化疗反应的预测®跨乳腺癌亚型: 一项回顾性横断面研究

BREAST
IF7.9
2024-08-011
OAAI
Comparative biological activity of palbociclib and ribociclib in hormone receptor-positive breast cancer
2024-07-112
OAAI